Viatris Inc
NASDAQ:VTRS
Viatris Inc
Retained Earnings
Viatris Inc
Retained Earnings Peer Comparison
Competitive Retained Earnings Analysis
Latest Figures & CAGR of Competitors
Company | Retained Earnings | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Viatris Inc
NASDAQ:VTRS
|
Retained Earnings
$4.6B
|
CAGR 3-Years
2%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
5%
|
|
Johnson & Johnson
NYSE:JNJ
|
Retained Earnings
$153.4B
|
CAGR 3-Years
10%
|
CAGR 5-Years
8%
|
CAGR 10-Years
5%
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Retained Earnings
$15.6B
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
-7%
|
|
Pfizer Inc
NYSE:PFE
|
Retained Earnings
$121.3B
|
CAGR 3-Years
8%
|
CAGR 5-Years
5%
|
CAGR 10-Years
5%
|
|
Merck & Co Inc
NYSE:MRK
|
Retained Earnings
$56.7B
|
CAGR 3-Years
5%
|
CAGR 5-Years
5%
|
CAGR 10-Years
4%
|
|
Eli Lilly and Co
NYSE:LLY
|
Retained Earnings
$12.6B
|
CAGR 3-Years
11%
|
CAGR 5-Years
21%
|
CAGR 10-Years
-3%
|
See Also
What is Viatris Inc's Retained Earnings?
Retained Earnings
4.6B
USD
Based on the financial report for Mar 31, 2024, Viatris Inc's Retained Earnings amounts to 4.6B USD.
What is Viatris Inc's Retained Earnings growth rate?
Retained Earnings CAGR 10Y
5%
Over the last year, the Retained Earnings growth was -12%. The average annual Retained Earnings growth rates for Viatris Inc have been 2% over the past three years , -5% over the past five years , and 5% over the past ten years .